Vidaza generic doing well for us; market share is increasing: Shilpa Medicare

The US Food and Drug Administration (US FDA) has given an all clear to Shilpa Medicare‘s formulation manufacturing facility at Jadcherla in Telangana. In an interview to CNBC-TV18, Vishnukant Bhutada, MD of the company spoke about the same.